Thalassemia major 1995: Older patients, new therapies
- 31 March 1995
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 9 (1) , 25-32
- https://doi.org/10.1016/0268-960x(95)90037-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Survival in Medically Treated Patients with Homozygous β-ThalassemiaNew England Journal of Medicine, 1994
- Decline in hepatitis B infection in sickle cell anaemia and beta thalassaemia major.Archives of Disease in Childhood, 1993
- Consequences of chronic hepatitis C: A review article for the hematologistAmerican Journal of Hematology, 1993
- Evaluation of Antibodies to Hepatitis C Virus in a Long-Term Prospective Study of Posttransfusion Hepatitis Among Thalassemic ChildrenJournal of Pediatric Gastroenterology and Nutrition, 1993
- Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia majorBritish Journal of Haematology, 1993
- Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patientsInfection, 1992
- The New Synthetic Hepatitis B Vaccine Administered at Low Doses by the Intradermal Route in Subjects at High Risk of Hepatitis BAnnals of the New York Academy of Sciences, 1990
- Treatment of Chronic Type C Hepatitis with Alpha InterferonSeminars in Liver Disease, 1989
- Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.Archives of Disease in Childhood, 1989